Table 3.
Baseline (week 1) |
Change Visits 1–6 |
P for change2 |
P for comparison of changes3 |
|
---|---|---|---|---|
Calories (g) | ||||
Placebo | 2297 ± 144 | −266 ± 100 | 0.01 | 0.61 |
Supplement | 2114 ± 145 | −193 ± 98 | 0.05 | |
Fiber (g) | ||||
Placebo | 24 ± 1.9 | −1.9 ± 1.1 | 0.10 | 0.51 |
Supplement | 24 ± 1.9 | −0.8 ± 1.1 | 0.47 | |
Fat (g) | ||||
Placebo | 79 ± 6.3 | −7.2 ± 4.2 | 0.09 | 0.86 |
Supplement | 72 ± 6.4 | −6.2 ± 4.1 | 0.14 | |
Protein (g) | ||||
Placebo | 102 ± 6.2 | −11 ± 5.0 | 0.04 | 0.99 |
Supplement | 91 ± 6.3 | −11 ± 4.9 | 0.04 | |
SFA (g) | ||||
Placebo | 27 ± 2.3 | −2.8 ± 1.5 | 0.07 | 0.70 |
Supplement | 24 ± 2.3 | −2.0 ± 1.5 | 0.20 | |
MUFA (g) | ||||
Placebo | 30 ± 2.5 | −2.6 ± 1.7 | 0.12 | 0.73 |
Supplement | 27 ± 2.5 | −1.8 ± 1.6 | 0.27 | |
PUFA (g) | ||||
Placebo | 15 ± 1.2 | −1.2 ± 0.9 | 0.17 | 0.79 |
Supplement | 14 ± 1.2 | −1.6 ± 0.9 | 0.08 | |
Omega-3 FA (g) | ||||
Placebo | 1.5 ± 0.12 | −0.1 ± 0.1 | 0.15 | 0.59 |
Supplement | 1.4 ± 0.12 | −0.2 ± 0.1 | 0.03 | |
Linoleic acid (g) | ||||
Placebo | 14 ± 1.1 | −1.1 ± 0.8 | 0.20 | 0.82 |
Supplement | 12 ± 1.1 | −1.3 ± 0.8 | 0.10 | |
Hours of Exercise per Week | ||||
Placebo | 4.5 ± 0.5 | −2.2 ± 0.6 | 0.001 | 0.35 |
Supplement | 3.3 ± 0.5 | −1.3 ± 0.6 | 0.04 | |
Sleep score (PSQ) | ||||
Placebo | 3.8 ± 0.3 | 0.1 ± 0.3 | 0.62 | 0.79 |
Supplement | 4.0 ± 0.3 | 0.3 ± 0.3 | 0.39 | |
Weight (lb) | ||||
Placebo | 162 ± 5.8 | −0.8 ± 0.8 | 0.35 | 0.60 |
Supplement | 152 ± 5.8 | −0.1 ± 0.8 | 0.86 |
All values are means +/− SEMs from mixed effects models. Tests are for orthogonal contrasts in the models. Fatty acids are from self-reported diet only as measured by the FFQ, and do not reflect plasma or PBMC changes.
Within-group tests
Between-group tests